Welcome to IRPB Lisbon 2015!
The IRPB 2015 Final Running Order is now available to download
Here is the IRPB 2015 final running order showing the details of all sessions, please click on it to download the pdf
Find the venue
Welcome to the new face of the IRPB. We have embraced technology and are going green with an app-based conference this year. Simply scan the codes on the left to download the app.
All the conference information will be available through the app along with a host of new features. You can create your own schedule, avoiding conflicts, contact other delegates and answer surveys all directly through the app. We hope you find it an advance over the old paper-based system and enjoy the new experience.
We will be looking into the theme of 'Optimization of therapy' for the conference and creating a programme split into sections to reflect this theme. The traditional, clinically-orientated expert reviews which make up the core of the IRPB will continue, as will sessions discussing new and existing pharmacological therapies, but these will be augmented by parallel sessions involving a variety of new themes and initiatives for 2015.
The conference will review recent exciting progress in genetic screening in Psychiatry, with special reference to how it can be used in the clinic today. Perhaps more importantly, we anticipate a lively debate on the ethics of genetic screening and appropriate patient counselling. In addition the conference will be reviewing adherence strategies and techniques to ensure optimal adherence and minimal relapse rates for patients, creating practical scenarios and workshops to help clinicians achieve long term remission for their patients.
The following table represents an overview of the current programme (click here download the pdf version)
Ensuring good compliance remains a key objective for both schizophrenia and bipolar disorders and remains an elusive ideal for many patients. New therapies have, in recent times, been introduced to attempt to help patients maintain a sufficient level of active drug substance on receptors in the brain. IRPB will review these new therapies and their utility amongst the wider patient population.
IRPB will be working with a number of associated organizations and offering sections of the programme to these organizations to design plenaries, interactive sessions, debates and workshops around the central theme, but from the point of view of the associated organization. Associated organizations can include commercially-orientated organizations.
Finally, Mental Health always seems to be an area struggling to remain sufficiently resourced, especially in these hard economic times. The conference will review Policy initiatives and ask if more can be done at National and International levels to help resourcing of services.
As we stand at the dawn of a new diagnostic age for Psychiatry, we look forward to a lively and exciting IRPB 2015.
With best wishes,
Conference and Association Director